HH

Hugo Hilton

Principal at Third Rock Ventures

San Francisco Bay Area

Overview 

Hugo Hilton is a Principal at Third Rock Ventures in the San Francisco Bay Area, with a background in molecular biology and cancer research. He has held senior roles at esteemed institutions like Stanford University and has a diverse educational background with a PhD from The University of Edinburgh and veterinary medicine degrees from University of Oslo and The University of Edinburgh.

Work Experience 

  • Principal

    2022 - Current

  • Senior Associate

    2020 - 2022

  • Senior Scientist II

    2019 - 2020

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Raised $496,000,000.00 from Logos Capital, Frazier Life Sciences, Janus Henderson Investors and Deep Track Capital.

  • Scientist

    2017 - 2019

Calico is an Alphabet-founded research and development company whose mission is to harness advanced technologies.

  • Research Scientist

    2014 - 2017

    Department of Structural Biology Department of Microbiology & Immunology (Laboratory of Peter Parham)

  • Post-Doctoral Fellow

    2009 - 2014

    Department of Structural Biology Department of Microbiology & Immunology (Laboratory of Peter Parham)

  • Research Assistant

    2009 - 2009

    Department of Surgical and Radiological Sciences (Laboratory of Jorge Nieto)

  • Resident in Equine Internal Medicine

    2006 - 2009

    Department of Medicine and Epidemiology

  • Large Animal Medicine Fellowship

    2005 - 2006

    Department of Clinical Sciences

Articles About Hugo

Relevant Websites